Visiting surgeon Peter Zhou was singing from the heart at the Sydney Opera House as part of the 300-strong Sydney Canaan Choir. The associate professor is a vascular surgeon from Shanghai Renji Hospital, and is working at Centenary for a year.
After months of preparation, the choir formed a blue and white cross on the stage of the Concert Hall and sang their “Heavenly Song” concert in front of an audience of more than 2000 people.
An artist's impression of the finish line in Ulaanbaatar, Mongolia — with Rupert Robey, Wil d'Avigdor, Ben Bradshaw and Dimitry Peisakhov.
There’s a link between driving across the Mongolian desert and liver research at the Centenary Institute. His name is Wil d’Avigdor—and next week he will exchange his role as mild-mannered Centenary PhD student studying the genetics of the hepatitis C virus for bold adventurer and member of Hard Yak, a four-man Australian taking part in the 2012 Mongol Rally team.
On Saturday 14 July Wil begins the drive of 15,000 km from London to Ulaanbaatar—risking life and limb to raise money for liver research at the Institute.
Professor Geoff McCaughan, head of Centenary’s liver program.
Prof Geoff McCaughan has an editorial in today’s Medical Journal of Australia saying that hepatitis C therapy is undergoing radical and rapid change. He predicts that within five years we will have short-duration anti-hepatitis C therapy with minimal side-effects and cure rates above 90%.
The burden of hepatitis C (HCV) associated liver failure and liver cancer is rising so these new drugs are just in time.